22 results  1 of 2 

1 Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single-Center Study
Xin Liu, Chengcheng Gong, Jieyun Zhang, Wanjing Feng, Yanjing Guo, Youzhou Sang, Chunmeng Wang, Yong Chen, Jian Wang, Lin Yu, Xiaowei Zhang, Zhiguo Luo
Cancer Res Treat.2023;55(3):1001-1010.   Published online 2023 March 3     DOI: http://dx.doi.org/10.4143/crt.2022.894
2 Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
Priyanka Singh, Aruna Nambirajan, Manish Kumar Gaur, Rahul Raj, Sunil Kumar, Prabhat Singh Malik, Deepali Jain
J Pathol Transl Med.2022;56(4):231-237.   Published online 2022 July 7     DOI: http://dx.doi.org/10.4132/jptm.2022.05.08
3 Lorlatinib Therapy for Rapid and Dramatic Control of Brain and Spinal Leptomeningeal Metastases From ALK-Positive Lung Adenocarcinoma
Min-Gwan Sun, In-Young Kim, Young-Jin Kim, Tae-Young Jung, Kyung-Sub Moon, Shin Jung, In-Je Oh, Young-Cheol Kim, Yoo-Duk Choi
Brain Tumor Res Treat.2021;9(2):100-105.   Published online 2021 October 21     DOI: http://dx.doi.org/10.14791/btrt.2021.9.e19
4 Anaplastic Lymphoma Kinase Positive Large B-cell Lymphoma Mimicking Metastatic Carcinoma of the Cervical Lymph Node from an Unknown Primary Lesion
Sang Woo Kim, Kyuho Lee, Bo Hae Kim, Eo Jin Kim
Korean J Otorhinolaryngol-Head Neck Surg.2021;64(10):760-765.   Published online 2021 May 25     DOI: http://dx.doi.org/10.3342/kjorl-hns.2020.00703
5 A case of concomitant EGFR/ALK alteration against a mutated EGFR background in early-stage lung adenocarcinoma
Ki-Chang Lee, Jiwon Koh, Doo Hyun Chung, Yoon Kyung Jeon
J Pathol Transl Med.2021;55(2):139-144.   Published online 2021 January 22     DOI: http://dx.doi.org/10.4132/jptm.2020.12.16
6 Characteristics of Renal Cell Carcinoma Harboring TPM3-ALK Fusion
Chang Gok Woo, Seok Jung Yun, Seung-Myoung Son, Young Hyun Lim, Ok-Jun Lee
Yonsei Med J.2020;61(3):262-266.   Published online 2020 February 20     DOI: http://dx.doi.org/10.3349/ymj.2020.61.3.262
7 Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing
Eunhyang Park, Hyo Sup Shim
Cancer Res Treat.2020;52(2):543-551.   Published online 2019 November 8     DOI: http://dx.doi.org/10.4143/crt.2019.305
8 Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer
Su-Jung Kim, Soyeon Kim, Dong-Wan Kim, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yusoo Lee, Jaemoon Koh, Yoon Kyung Jeon, Dae Seog Heo
Cancer Res Treat.2019;51(3):1231-1240.   Published online 2018 December 31     DOI: http://dx.doi.org/10.4143/crt.2018.486
9 Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors
Jongmin Sim, Hyunjin Kim, Jiyeon Hyeon, Yoon-La Choi, Joungho Han
J Korean Med Sci.2018;33(15):e123.  Published online 2018 April 3     DOI: http://dx.doi.org/10.3346/jkms.2018.33.e123
10 Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer
Jaemin Jo, Se Hyun Kim, Yu Jung Kim, Juhyun Lee, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jin-Haeng Chung, Yoon Kyung Jeon, Jong Seok Lee
Yonsei Med J.2018;59(2):202-210.   Published online 2018 February 5     DOI: http://dx.doi.org/10.3349/ymj.2018.59.2.202
11 Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase‒Positive Anaplastic Large Cell Lymphoma
Wendan Xu, Ji-Won Kim, Woo June Jung, Youngil Koh, Sung-Soo Yoon
Cancer Res Treat.2018;50(2):599-613.   Published online 2017 June 19     DOI: http://dx.doi.org/10.4143/crt.2016.357
12 ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor
Ji Won Lee, Sung Hye Park, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn
Cancer Res Treat.2018;50(2):495-505.   Published online 2017 May 22     DOI: http://dx.doi.org/10.4143/crt.2016.577
13 Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
Katherine M. Krajewski, Marta Braschi-Amirfarzan, Pamela J. DiPiro, Jyothi P. Jagannathan, Atul B. Shinagare
Korean J Radiol.2017;18(1):28-41.   Published online 2017 January 5     DOI: http://dx.doi.org/10.3348/kjr.2017.18.1.28
14 CD30-Positive Anaplastic Lymphoma Kinase-Negative Systemic Anaplastic Large-Cell Lymphoma in a 9-Year-Old Boy
Jeong Eun Kim, Eui Hyun Oh, Young Suck Ro, Joo Yeon Ko
Ann Dermatol.2016;28(3):371-374.   Published online 2016 May 25     DOI: http://dx.doi.org/10.5021/ad.2016.28.3.371
15 Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
Taebum Lee, Boram Lee, Yoon-La Choi, Joungho Han, Myung-Ju Ahn, Sang-Won Um
J Pathol Transl Med.2016;50(3):197-203.   Published online 2016 April 18     DOI: http://dx.doi.org/10.4132/jptm.2016.03.09
16 Analysis of Histologic Features Suspecting Anaplastic Lymphoma Kinase (ALK)-Expressing Pulmonary Adenocarcinoma
In Ho Choi, Dong Won Kim, Sang Yun Ha, Yoon-La Choi, Hee Jeong Lee, Joungho Han
J Pathol Transl Med.2015;49(4):310-317.   Published online 2015 June 22     DOI: http://dx.doi.org/10.4132/jptm.2015.05.13
17 SEC31A-ALK Fusion Gene in Lung Adenocarcinoma
Ryong Nam Kim, Yoon-La Choi, Mi-Sook Lee, Maruja E. Lira, Mao Mao, Derrick Mann, Joshua Stahl, Abel Licon, So Jung Choi, Michael Van Vrancken, Joungho Han, Iwona Wlodarska, Jhingook Kim
Cancer Res Treat.2016;48(1):398-402.   Published online 2015 February 17     DOI: http://dx.doi.org/10.4143/crt.2014.254
18 Bilateral Ovarian Metastases from ALK Rearranged Non-Small Cell Lung Cancer
Kyung Ann Lee, Jong Sik Lee, Jae Ki Min, Hee Joung Kim, Wan Seop Kim, Kye Young Lee
Tuberc Respir Dis.2014;77(6):258-261.   Published online 2014 December 31     DOI: http://dx.doi.org/10.4046/trd.2014.77.6.258
19 The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer
June-Koo Lee, Dong-Wan Kim, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Young-Joo Kim, Dae Seog Heo
Cancer Res Treat.2015;47(2):182-188.   Published online 2014 September 12     DOI: http://dx.doi.org/10.4143/crt.2013.227
20 Histologic Features of ALK-Expressing Adenocarciomas of the Lung
Hye-Jong Song, Ji Yun Jeong, Yoonla Choi, Joungho Han
J Lung Cancer.2011;10(1):32-36.   Published online 2011 January 11     DOI: http://dx.doi.org/10.6058/jlc.2011.10.1.32

 1 of 2